You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 160 No. 13, July 10, 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Trouble With Triglycerides

Arch Intern Med. 2000;160:1903-1904.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

DESPITE DECADES of debate, the question of whether the triglyceride level is an "independent" risk factor for coronary heart disease (CHD) still generates considerable controversy. If, after all this time, we do not have an answer to this question, it is probably time to ask a different question. That question, addressed in part in the article by Avins and Neuhaus1 in this issue of the ARCHIVES, is not whether the triglyceride level is an independent risk factor for CHD, but whether it is a useful test for the clinician interested in the prevention and treatment of CHD.

A useful test is one that, at acceptable cost, convenience, and safety, affects diagnosis, prognosis, or therapy. For triglyceride levels and CHD, the issue is whether knowing a patient's triglyceride level has any therapeutic or prognostic implications. No clinical trials have been conducted to determine if lowering triglyceride levels decreases cardiovascular events. Major . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Triglyceride Level: A Predictive Risk Factor for Atherosclerosis?
Thomas F. Whayne, Jr, Judy C. Zielke, Andrew L. Avins, and John M. Neuhaus
Arch Intern Med. 2001;161(2):295-296.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Do Triglycerides Provide Meaningful Information About Heart Disease Risk?
Andrew L. Avins and John M. Neuhaus
Arch Intern Med. 2000;160(13):1937-1944.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ApoC-III gene polymorphisms and risk of coronary artery disease
Olivieri et al.
J. Lipid Res. 2002;43:1450-1457.
ABSTRACT | FULL TEXT  

Evidence based management of hypertension: Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review
Padwal et al.
BMJ 2001;322:977-980.
FULL TEXT  

Primary Prevention of Coronary Heart Disease: Where Do We Go From Here?
Gotto
Arch Intern Med 2001;161:922-924.
FULL TEXT  

Triglyceride Level: A Predictive Risk Factor for Atherosclerosis?
Whayne et al.
Arch Intern Med 2001;161:295-296.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.